Furthermore, the levels of NET products and IL-8 observed in plasma could be used as biomarkers to determine the disease severity of COVID-19 patients, particularly NE and MPO–DNA complexes, which are mainly produced by neutrophils and more specific to NET formation (Figure 1B,D). This evidence concerns the gene CXCL8 and COVID-19.